For a complete discussion of the Company’s quantitative and qualitative disclosures about market risks, see the section titled Quantitative and Qualitative Disclosures About Market Risks in our 2025 Annual Report. Except as described below, there has been no material change in this information as of June 30, 2026. Interest Rates The primary objective of our investment activities is to preserve principal while at the same time maximizing after-tax yields without significantly increasing risk. To achieve this objective, we maintain our investment portfolio of cash equivalents and marketable securities in a variety of securities, including government securities, corporate debt securities, and commercial paper. We have not used derivative financial instruments in our investment portfolio, and none of our investments are held for trading or speculative purposes. Short-term and long-term debt securities are generally classified as available-for-sale and consequently are recorded on the condensed consolidated balance sheets at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income, net of estimated tax. As of June 30, 2026, our marketable securities had remaining maturities between approximately one and 13 months and a fair market value of $10.1 million, representing 3% of our total assets. The fair value of our cash equivalents and debt securities is subject to change as a result of changes in market interest rates and investment risk related to the issuers’ credit worthiness. We do not utilize financial contracts to manage our investment portfolio’s exposure to changes in market interest rates. A hypothetical 100 basis point increase or decrease in market interest rates would not have a material impact on the fair value of our cash equivalents and debt securities due to the relatively short maturities of these investments. While changes in market interest rates may affect the fair value of our investment portfolio, any gains or losses will not be recognized in our results of operations unless the investment is sold prior to maturity or if the reduction in fair value was determined to be an other-than-temporary impairment. We are also exposed to interest rate risk on our Term Loan under the Amended Credit Agreement, which bears interest at a variable rate tied to term SOFR or the WSJ prime rate. As of June 30, 2026, $49.4 million was outstanding under the Term Loan. A hypothetical 100 basis point increase in the applicable variable rate would increase annual interest expense by approximately $0.5 million, based on the outstanding principal balance as of June 30, 2026. A hypothetical 100 basis point decrease would reduce annual interest expense by a corresponding amount, subject to any applicable interest rate floor under the Amended Credit Agreement. Foreign Currency Risk There have been no material changes to our foreign currency exchange rate risk from that described in Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in the 2025 Annual Report. The Company continues to have operations in the United Kingdom, France, the Netherlands, and Spain, exposed to fluctuations between the U.S. dollar and the Euro and the British pound sterling, and translation adjustments continue to be reported separately in the condensed consolidated statements of operations and comprehensive income (loss). Inflation There have been no material changes to our exposure to inflation risk from that described in the 2025 Annual Report. Inflation did not have a material effect on our business, financial condition or results of operations during either of the nine months ended June 30, 2026 or 2025. 26